EDIT vs VRTX
EDIT 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | EDITEDITAS MEDICINE, INC. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | $393.16M | $144.47B |
| 市盈率(TTM) | — | 33.2 |
| 市净率 | — | 7.14 |
| 市销率 | 10.0x | 11.9x |
| 营收 | — | $12.59B(TTM) |
| 营收同比增长 | 25.4% | 8.9% |
| 净利润 | — | $4.41B(TTM) |
| 净利同比增长 | 32.5% | 838.1% |
| 每股收益(稀释) | — | $17.17(TTM) |
| 息税前利润率 | -394.9% | 34.8% |
| 净资产收益率 | -152.0% | 19.5% |
| 投入资本回报率 | — | 25.0% |
| 一年总回报 | -14.0% | +32.4% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:EDIT vs VRTX
| 指标 | EDIT | VRTX |
|---|---|---|
| 期末价值 | $1.1K | $64.3K |
| 总回报 | -89.5% | +543.0% |
| 年化收益 (CAGR) | -19.6% | +19.7% |
| 波动率 | 83.6% | 32.6% |
| 夏普比率 | 0.09 | 0.59 |
| 索提诺比率 | 0.14 | 0.87 |
| 最大回撤 | -98.9% | -41.6% |
基于 2600 个共同交易日,2016-06-30 → 2026-11-02 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)